MED (Medifast) Debt-to-Equity : 0.08 (As of Dec. 2024)

View and export this data going back to 1981. Start your Free Trial

What is Medifast Debt-to-Equity?

Medifast's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $6.2 Mil. Medifast's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was $9.9 Mil. Medifast's Total Stockholders Equity for the quarter that ended in Dec. 2024 was $210.1 Mil. Medifast's debt to equity for the quarter that ended in Dec. 2024 was 0.08.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Medifast's Debt-to-Equity or its related term are showing as below:

MED' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.11 Max: 0.17
Current: 0.08

During the past 13 years, the highest Debt-to-Equity Ratio of Medifast was 0.17. The lowest was 0.00. And the median was 0.11.

MED's Debt-to-Equity is ranked better than
87.5% of 88 companies
in the Personal Services industry
Industry Median: 0.62 vs MED: 0.08

Medifast Debt-to-Equity Historical Data

The historical data trend for Medifast's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medifast Debt-to-Equity Chart

Medifast Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Equity

Get a 7-Day Free Trial

0.07

0.16

0.17

0.11

0.08

Medifast Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															0.11	0.10	0.09	0.09	0.08

Competitive Comparison of Medifast's Debt-to-Equity

For the Personal Services subindustry, Medifast's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medifast's Debt-to-Equity Distribution in the Personal Services Industry

For the Personal Services industry and Consumer Cyclical sector, Medifast's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Medifast's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Medifast Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Medifast's Debt to Equity Ratio for the fiscal year that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.182	+	9.943)	/	210.109
	=	0.08

Medifast's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(6.182	+	9.943)	/	210.109
	=	0.08

Medifast (NYSE:MED) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Medifast Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Medifast's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Medifast Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Cyclical » Personal Services » Medifast Inc (NYSE:MED) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

0K05:UK MDF:Germany MDF:Germany

Address

100 International Drive, Baltimore, MD, USA, 21202

Website

https://www.medifastinc.com

Medifast Inc is a old health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA, which provides people with a simple, yet comprehensive approach to address obesity and support a healthy life. OPTAVIA provides unparalleled coaching support along with community, tailored nutrition and healthy habits, and empowers people to master their weight loss journey through each stage of life. The company has access to GLP-1 medications where clinically appropriate. Medifast remains committed to its mission of offering Lifelong Transformation, Making a Healthy Lifestyle Second Nature.

Executives

Scott Schlackman	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Jeffrey J Brown	director	19900 MACARTHUR BLVD, SUITE 570, IRVINE CA 92612
Andrea B Thomas	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Michael A. Hoer	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Hallquist Constance J.	director	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Elizabeth A. Geary	director	C/O MEDIFAST, INC., 100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Daniel R Chard	director, officer: Chief Executive Officer	NU SKIN ENTERPRISES, INC., 75 WEST CENTER STREET, PROVO UT 84601
Jonathan Barrett Mackenzie	officer: VP, Finance & CAO	100 INTERNATIONAL DRIVE, BALTIMORE MD 21202
Kevin G Byrnes	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Michael C Macdonald	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
James P. Maloney	officer: Chief Financial Officer	415 HOLIDAY DRIVE, PITTSBURGH PA 15220
Ming Xian	director	MEDIFAST, INC., 100 INTERNATIONAL DRIVE, 18TH FLOOR, BALTIMORE MD 21202
Carl E Sassano	director	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117
Joseph P Kelleman	officer: (Interim) CFO	3600 CRONDALL LANE, OWINGS MILLS MD 21117
Timothy G Robinson	officer: Chief Financial Officer	C/O MEDIFAST, INC., 3600 CRONDALL LANE, OWINGS MILLS MD 21117